The effects of compound Danshen Dripping Pills and human umbilical cord blood mononuclear cell transplant after acute myocardial infarction

Experimental and Clinical Transplantation

Volumn 12, Issue 2, 2014, Pages 123-128

  Yi, Jun ^a   Yuan, Chunju ^a   Ai, Qi ^a   Deng, Liuxia ^a   Yu, Guolong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Inflammation; Left ventricular ejection fraction; Left ventricular fraction shortening; Oxidative stress

Indexed keywords

CHINESE DRUG; COMPOUND DANSHEN DRIPPING PILL; GREEN FLUORESCENT PROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; FUFANG DANSHEN; HERBACEOUS AGENT;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVITY; EXPERIMENTAL RABBIT; FEMALE; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HISTOLOGY; INFLAMMATION; LEUKOCYTE COUNT; MALE; MICROENVIRONMENT; NONHUMAN; OXIDATIVE STRESS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; METABOLISM; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; STEM CELL NICHE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RABBITS; STEM CELL NICHE; STROKE VOLUME; SUPEROXIDE DISMUTASE; VENTRICULAR FUNCTION, LEFT;

EID: 84898620332     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2013.0204     Document Type: Article

References (16)

1. Dai W, Kloner RA. Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions. Am J Transplant. 2011;11(11):2297-2301.
2. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58(11):1095-1104.
3. Beitnes JO, Lunde K, Brinchmann JE, Aakhus S. Stem cells for cardiac repair in acute myocardial infarction. Expert Rev Cardiovasc Ther. 2011;9(8):1015-1025.
4. Noort WA, Feye D, Van Den Akker F, et al. Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva Med. 2010;52(1):27-40.
5. Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54(24):2277-2286.
6. Yu G, Borlongan CV, Stahl CE, et al. Transplantation of human umbilical cord blood cells for the repair of myocardial infarction. Med Sci Monit. 2008;14(10):RA163-RA172.
7. Joggerst SJ, Hatzopoulos AK. Stem cell therapy for cardiac repair: benefits and barriers. Expert Rev Mol Med. 2009;11:e20.
8. Xin X, Zou H, Zheng N, et al. Metabonomic strategy to the evaluation of Chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats. Evid Based Complement Alternat Med. 2013;2013:718305.
9. Wang S, Wang ZJ, Zhao F. Experimental study on protective effects of tanshinol on oxidative stress injured vascular endothelial cell [in Chinese]. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2011;15(20):2493-2494, 2496.
10. Lin XD. Clinical trial of Compound Danshen Dripping Pill on ventricular remodeling after acute myocardial infarction [in Chinese]. World Chinese Medicine. 2011;5(2):111-112.
11. Luo J, Xu H. Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews. Evid Based Complement Alternat Med. 2012;2012:927392.
12. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cellbased therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J. 2011;32(10):1197-1206.
13. Anonymous compound danshen dripping pills passed Phase II clinical trials by FDA. China J Pharm Econ. 2010;4:94.
14. Shi RZ, Li QP. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun. 2008;376(2):247-250.
15. Lin SQ, Wei XH, Liu YY, et al. Improving effect of Compound Danshen Dripping Pill on cardiac superficial blood flow and myocardial damage of I/R rats [in Chinese]. Journal of Chinese Microcirculation. 2012;22(2):21-23.
16. Zhao N, Liu YY, Wang F, et al. Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am J Physiol Heart Circ Physiol. 2010;298(4):H1166-H1176.